Pierre Jean-Marie Bernard Raboisson,Dominique Louis Nestor Ghislain Surleraux,Tse-I Lin,Oliver Lenz,Kenneth Alan Simmen
申请号：
US15620343
公开号：
US20170275288A1
申请日:
2017.06.12
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to the use of pteridines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections. In addition, the present invention relates to compounds per se and their use as medicines. The present invention also concerns processes for the preparation of such compounds, pharmaceutical compositions comprising them, and combinations of said compounds with other anti-HCV agents.
